CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model. (2020)

First Author: Felce SL
Attributed to:  University of Oxford Confidence in Concept Scheme – Round 5 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fonc.2020.00448

PubMed Identifier: 32309216

Publication URI: http://europepmc.org/abstract/MED/32309216

Type: Journal Article/Review

Volume: 10

Parent Publication: Frontiers in oncology

ISSN: 2234-943X